<!DOCTYPE HTML>
<!--
	Editorial by HTML5 UP
	html5up.net | @ajlkn
	Free for personal and commercial use under the CCA 3.0 license (html5up.net/license)
-->
<html>
	<head>
		<title>Generic - Editorial by HTML5 UP</title>
		<meta charset="utf-8" />
		<meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no" />
		<link rel="stylesheet" href="assets/css/main.css" />
	</head>
	<body class="is-preload">

		<!-- Wrapper -->
			<div id="wrapper">

				<!-- Main -->
					<div id="main">
						<div class="inner">

							<!-- Header -->
								<header id="header">
									<a href="index.html" class="logo"><strong>CELL Team Six</strong></a>
								</header>

							<!-- Content -->
								<section>
									<header class="main">
										<h1>Anaplastic lymphoma kinase (ALK)</h1>
									</header>


									<center><span class="Fit"><img src="images/ras.png" alt="" width=50% length=auto /></span></center>

									<center><b>Fig 1.</b> Known Ras signalling pathways<a href="https://www.abcam.com/index.html?pageconfig=resource&rid=15207"><sup>1</sup></a> </center> <br><br>

									Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that belongs to the insulin superfamily. ALK plays a role in the functioning of the nervous system as well as its development. Phosphorylated ALK activates several signalling pathways such as MAPK-ERK, PLC and PI3K-AKT. Abnormalities in the ALK pathway result in cancer development, such as anaplastic large cell lymphoma, neuroblastoma, or non-small lung cancer. Carcinogenesis results from ALK gene fusion with oncogenes, gene mutation, amplification, and an increase in protein expression. Usually, these genetic changes lead to constitutively active ALK receptor tyrosine kinase, consequently activating downstream signaling pathways and leading to uncontrolled cell growth, anti-apoptotic signaling, and cellular transformation. ALK can form a fusion protein with nucelophosmin (NPM) on the amino-terminal as a result of chromosomal translocation. Approximately 70% to 80% of anaplastic large cell lymphomas (ALCL) are associated with NPM-ALK. NPM-ALK activates the Ras-ERK signalling pathway which feeds into cell proliferation <a href="https://www.creative-diagnostics.com/alk-pathway.htm"><sup>2</sup></a><sup>,</sup><a href="https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-018-0776-2"><sup>3</sup></a>.

									<br><br>
									<h3>References:</h3>
<ol>
<li>Abcam.com. 2021. Ras signaling in cancer [Online website] Available at: https://www.abcam.com/index.html?pageconfig=resource&rid=15207 [Accessed 22 March 2021].
<li>Creative-diagnostics.com. 2021. ALK Pathway - Creative Diagnostics. [online] Available at: https://www.creative-diagnostics.com/alk-pathway.htm [Accessed 22 March 2021].
<li>Della Corte C.M., Viscardi G., Di Liello R., Fasano M., Martinelli E., Troiani T., Ciardiello F., Morgillo F. 2018. Role and targeting of anaplastic lymphoma kinase in cancer. Mol. Cancer, 17.
</ol>


								</section>

						</div>
					</div>

				<!-- Sidebar -->
					<div id="sidebar">
						<div class="inner">



							<!-- Menu -->
								<nav id="menu">
									<header class="major">
										<h2>Menu</h2>
									</header>
									<ul>
										<li><a href="index.html">ALK pathway</a></li>
										<li><a href="ras.html">Ras family</a></li>
										<li>
											<span class="opener">Sequence information</span>
											<ul>
												<li><a href="fasta.html">FASTA</a></li>
												<li><a href="msa.html">Multiple Sequence Alignment</a></li>
												<li><a href="blast.html">BLAST</a></li>
											</ul>
										</li>
										<li>
											<span class="opener">Structure</span>
											<ul>
												<li><a href="s_overview.html">Overview</a></li>
												<li><a href="s_loop.html">P-loop</a></li>
												<li><a href="s_switch1.html">Switch I</a></li>
												<li><a href="s_switch2.html">Switch II</a></li>
												<li><a href="s_g4g5.html">G4, G5, HVR</a></li>
											</ul>
										</li>
										<li><a href="summary.html">Summary</a></li>
									</ul>
								</nav>


							<!-- Section -->
								<section>
									<header class="major">
										<h2>Created by</h2>
									</header>
									Kornelija Bakutyte<br>
									Ines Fernandez Mosquera<br>
									Yasmine Metaxa<br>
									Thomas Roberts<br>
									Filip Wilk<br>




								</section>

							<!-- Footer -->
								<footer id="footer">
									<p class="copyright">&copy; All rights reserved. Design: <a href="https://html5up.net">HTML5 UP</a>.</p>
								</footer>

						</div>
					</div>

			</div>

		<!-- Scripts -->
			<script src="assets/js/jquery.min.js"></script>
			<script src="assets/js/browser.min.js"></script>
			<script src="assets/js/breakpoints.min.js"></script>
			<script src="assets/js/util.js"></script>
			<script src="assets/js/main.js"></script>

	</body>
</html>
